Removing different number of regional lymph nodes affects survival outcomes of operable patients at stage IIA non-small cell lung cancer (according to the 8th edition staging)

BACKGROUND: Surgery combined with chemotherapy (CT) is the best treatment for tumor patients at stage I to IIIA. But there are only few studies specifically evaluated the survival benefits of removing different number of regional lymph nodes (RLNs) for patients with stage IIA non-small cell lung can...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xuan, Li, Guoshu, Wang, Yukun, Tan, Min, Wang, Changhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992567/
https://www.ncbi.nlm.nih.gov/pubmed/36910092
http://dx.doi.org/10.21037/jtd-22-1314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992567/
https://www.ncbi.nlm.nih.gov/pubmed/36910092
http://dx.doi.org/10.21037/jtd-22-1314

Ejemplares similares